Events

Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: Assess the current minimal residual disease testing modalities/methods  Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities […]

Join the MDR for patients with germline predisposition for hematological malignancies. This meeting is for clinicians within the Nordics.via this Zoom-link. If you want to discuss a case,  please send 1-2 summary slides with the most important information to Panagiotis Baliakas (panagiotis.baliakas@igp.uu.se), Uppsala, Sweden.